These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does executive impairment define a frontal variant of Alzheimer's disease? Woodward M, Brodaty H, Boundy K, Ames D, Blanch G, Balshaw R, PRIME Study Group. Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041 [Abstract] [Full Text] [Related]
3. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration. Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J. Dement Geriatr Cogn Disord; 2010 Dec; 29(5):448-56. PubMed ID: 20502019 [Abstract] [Full Text] [Related]
4. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory. Konstantinopoulou E, Aretouli E, Ioannidis P, Karacostas D, Kosmidis MH. Int J Geriatr Psychiatry; 2013 Sep; 28(9):939-46. PubMed ID: 23135894 [Abstract] [Full Text] [Related]
5. Detecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia. Mioshi E, Flanagan E, Knopman D. Int J Geriatr Psychiatry; 2017 Sep; 32(9):977-982. PubMed ID: 27464599 [Abstract] [Full Text] [Related]
6. Measurement and characterization of distinctive clinical phenotypes using the Frontotemporal Lobar Degeneration Module (FTLD-MOD). Gefen T, Teylan MA, Besser L, Pollner E, Moshkovich A, Weintraub S. Alzheimers Dement; 2020 Jun; 16(6):918-925. PubMed ID: 32400973 [Abstract] [Full Text] [Related]
7. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Gordon E, Rohrer JD, Kim LG, Omar R, Rossor MN, Fox NC, Warren JD. Neurology; 2010 Feb 23; 74(8):666-73. PubMed ID: 20177120 [Abstract] [Full Text] [Related]
8. Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration. Duignan JA, Haughey A, Kinsella JA, Killeen RP. Semin Nucl Med; 2021 May 23; 51(3):264-274. PubMed ID: 33402272 [Abstract] [Full Text] [Related]
9. Are we comparing frontotemporal dementia and Alzheimer disease patients with the right measures? Deutsch MB, Liang LJ, Jimenez EE, Mather MJ, Mendez MF. Int Psychogeriatr; 2016 Sep 23; 28(9):1481-5. PubMed ID: 27079571 [Abstract] [Full Text] [Related]
10. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. Borroni B, Agosti C, Premi E, Cerini C, Cosseddu M, Paghera B, Bellelli G, Padovani A. Eur J Neurol; 2010 May 23; 17(5):703-7. PubMed ID: 20050899 [Abstract] [Full Text] [Related]
11. The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease. Das S, van Engelen ME, Goossens J, Jacobs D, Bongers B, Fieldhouse JLP, Pijnenburg YAL, Teunissen CE, Vanmechelen E, Verberk IMW. Alzheimers Res Ther; 2024 Feb 14; 16(1):34. PubMed ID: 38355535 [Abstract] [Full Text] [Related]
12. Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration. Binney RJ, Pankov A, Marx G, He X, McKenna F, Staffaroni AM, Kornak J, Attygalle S, Boxer AL, Schuff N, Gorno-Tempini ML, Weiner MW, Kramer JH, Miller BL, Rosen HJ. Brain Behav; 2017 Apr 14; 7(4):e00675. PubMed ID: 28413716 [Abstract] [Full Text] [Related]
13. Disease Progression in Frontotemporal Dementia and Alzheimer Disease: The Contribution of Staging Scales. Lima-Silva TB, Mioshi E, Bahia VS, Cecchini MA, Cassimiro L, Guimarães HC, Gambogi LB, Caramelli P, Balthazar M, Damasceno B, Brucki SMD, de Souza LC, Nitrini R, Yassuda MS. J Geriatr Psychiatry Neurol; 2021 Sep 14; 34(5):397-404. PubMed ID: 32762416 [Abstract] [Full Text] [Related]
14. [New entities and the criteria of FTLD]. Otsuki M. Nihon Rinsho; 2016 Mar 14; 74(3):459-65. PubMed ID: 27025087 [Abstract] [Full Text] [Related]
15. The frontotemporal dementias in a tertiary referral center: classification and demographic characteristics in a series of 232 cases. Ioannidis P, Konstantinopoulou E, Maiovis P, Karacostas D. J Neurol Sci; 2012 Jul 15; 318(1-2):171-3. PubMed ID: 22541253 [Abstract] [Full Text] [Related]
16. Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease. Elahi FM, Marx G, Cobigo Y, Staffaroni AM, Kornak J, Tosun D, Boxer AL, Kramer JH, Miller BL, Rosen HJ. Neuroimage Clin; 2017 Jul 15; 16():595-603. PubMed ID: 28975068 [Abstract] [Full Text] [Related]
17. Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration. Kawakami I, Arai T, Shinagawa S, Niizato K, Oshima K, Ikeda M. Int J Geriatr Psychiatry; 2021 Jan 15; 36(1):38-45. PubMed ID: 32748432 [Abstract] [Full Text] [Related]
18. Frontotemporal lobar degeneration: a clinical approach. Karageorgiou E, Miller BL. Semin Neurol; 2014 Apr 15; 34(2):189-201. PubMed ID: 24963678 [Abstract] [Full Text] [Related]
19. Clinical accuracy of the distinction between Alzheimer's disease and frontotemporal lobar degeneration. Sutovsky S, Blaho A, Kollar B, Siarnik P, Csefalvay Z, Dragasek J, Turcani P. Bratisl Lek Listy; 2014 Apr 15; 115(3):161-7. PubMed ID: 24579686 [Abstract] [Full Text] [Related]
20. The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment. Suhonen NM, Hallikainen I, Hänninen T, Jokelainen J, Krüger J, Hall A, Pikkarainen M, Soininen H, Remes AM. J Alzheimers Dis; 2017 Apr 15; 56(4):1241-1251. PubMed ID: 28106561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]